IIn this episode of the Plant Medicine Podcast, Carlos Tanner Joins to share his story of addiction, and how participating in ayahuasca ceremonies not only led him to personal healing but started him down a path of becoming a traditional healer himself.
Read MoreThis week’s episode of the Plant Medicine Podcasts features guest Aaron Orsini, co-founder of the Autistic Psychedelic Community and author of Autism on Acid: How LSD Helped Me Understand, Navigate, Alter & Appreciate my Autistic Perceptions. In this interview, Aaron gives an overview of his own experiences with autism and how psychedelics changed his relationship with his condition, while also providing fascinating insights into some of the neuroscientific research on both autism and psychedelic experiences.
Read MoreIn this episode, host Dr. Lynn Marie Morski, who is also president of the soon-to-be-launched Psychedelic Medicine Association, discusses what services the association will be providing, what needs it will address, and how the collaborations fostered in the association will contribute to real-world improvements in access to psychedelic therapies.
Read MoreDr. Adolph shares the brief history of how ketamine was originally created, how it came to be used in the mental health arena, and its effectiveness for those with depression. He covers what the research has shown, as well as what he’s seen in his clinic and in his own personal journey with the medicine.
Read MoreIn this episode, Dr. Pate discusses how traumatic brain injuries (TBI) share many commonalities with the symptoms of PTSD. She discusses why it may be wise to tend to healing the physical brain prior to or in parallel to attempting to heal one’s mental trauma. Dr. Pate also shares about the healing potential of the ayahuasca brew, independent of its DMT content.
Read MoreIn this episode, Dr. Malcolm discusses how antidepressants react with MDMA, psilocybin, DMT, 5-MeO-DMT, ayahuasca, and ketamine. He also explains the risk profiles for interactions between psychedelics and medications such as benzodiazepines, sleep medication, antipsychotics, and lithium.
Read MoreIn this episode, Dr. Malcolm discusses how antidepressants react with MDMA, psilocybin, DMT, 5-MeO-DMT, ayahuasca, and ketamine. He also explains the risk profiles for interactions between psychedelics and medications such as benzodiazepines, sleep medication, antipsychotics, and lithium.
Read MoreIn this episode, Dr. Fadiman answers listener-submitted questions regarding microdosing psilocybin and LSD. He discussed dosing recommendations, tolerance, microdosing's general effects on healthy normals, and its specific effects on a number of conditions, ranging from depression to PMS. He also covered a variety of additional areas where people benefit from microdosing, including academic performance and athletics.
Read MoreIn this episode, Mike discusses what a kambo ceremony looks & feels like, and how to both prepare for it beforehand and integrate it afterward. Mike shares how he was first introduced to kambo as “the warrior’s medicine” and the comprehensive training he underwent to be able to hold space for others. He also gives an overview about the uses of two other plant medicines called rapé and sananga.
Read MoreIn this episode, Caitlin Thompson discusses what we know and what we don’t know about kambo is and how it actually works. Having served kambo over 800 times, she shares the physiological and psychological changes people undergo when they experience the cocktail of peptides present in kambo.
Read MoreLucresia has been on a long healing journey, both physically and spiritually. Physically, she had endured a number of chronic issues, like celiac disease and exposure to mold toxicity. She had felt like she had tried it all and did not know what else to do. In talking with some ayahuasca practitioners, she was introduced to a Kambo practitioner. Even though the intense experience of Kambo seemed scary for her, she was in a place where she was willing to try anything.
Read MoreDel Jolly is cofounder and director of Unlimited Sciences, a psychedelic research non-profit. He was the outreach director for the Decriminalize Denver team that passed the historic legislation which decriminalized psilocybin in Denver, leading to a nation-wide movement. Before that, he worked for Charlotte’s Web CBD in business development and is on the board of community advisors for the Realm of Caring, a cannabis non-profit.
Read MoreIn this episode, Chris Timmerman discusses what happens neurologically when DMT is administered. He talks about his research into neuroimaging and how the brainwaves change during DMT experiences, and how those changes can help elucidate some of the mechanisms of psychedelic states.
Read MoreIn this week's episode, Adam goes into detail about what he experienced during multiple DMT journeys. He talks about how intense his first experience was and what he felt in the DMT space. He also compares how different his later experiences were.
Read MoreIn this week’s episode, Zappy and Warren share their stories, and what led them to advocate for ketamine treatments. Noticing how expensive this therapy can be, Zappy and Warren wanted to help veterans who would benefit the most by subsidizing this treatment.
Read MoreIn this episode, Mike discusses his research into mescaline and its extended history. Mike shares the cultural significance of huachuma and peyote for indigenous tribes in Mexico and Peru dating back over 3000 years. He also talks about western research into mescaline starting in the 19th century, and even mentions how peyote was almost incorporated into the Mormon Church!
Read MoreIn this week’s episode, Tah and Kole discuss how their paths led to facilitating huachuma (San Pedro) ceremonies. While they both were initially resistant to using plant medicine, they discovered how impactful huachuma ceremonies can be to resolve pent up trauma.
Read MoreIn this week’s episode, Joe discusses how he and his co-founder, Kyle Buller started Psychedelics Today, and how their podcast led to them developing a number of online courses. Their upcoming course is Navigating Psychedelics for Clinicians and Therapists.
Read MoreIn this week’s episode, Ian-Michael describes his very personal journey as he experienced mescaline while hiking through the Grand Canyon. Ian-Michael Hebert is committed to healing the relationship between humanity and the Earth. His formal training has been in eco-resort design and he holds a Masters degree in Counseling Psychology and community mental health. He is the founder of Holos Global, a network of holistic healing centers. Ian-Michael has catalyzed many teams in creating enduring structures and institutions that will benefit generations to come.
Read MoreDr. Joseph Peter Barsuglia is a clinical psychologist focused on bridging ancestral medicines and wisdom with best clinical practices, in order to catalyze personal healing and spiritual awakening. He has worked as Research Director of a psychedelic treatment center which utilized 5-MeO-DMT and ibogaine for the treatment of addiction, as a psychotherapist in the MAPS-sponsored trials of MDMA-assisted psychotherapy for PTSD, and is an initiate of the African tradition called Bwiti which uses iboga as its sacrament.
Read More
